Browsing: Upto

Eli Lilly’s biotech buying spree continues as the pharma giant is planning to carry out its 13th buyout of a biotech this year, agreeing to acquire Merida Biosciences, a developer of precision therapies for serious autoimmune and allergic diseases, for up to $2.875 billion, the companies said